Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
BRTX: BioRestorative Therapies, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
BRTX
The Story
BRTX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-10.3% / yr
Operating margin
-3975.0%
ROIC
-464.9%
Financially safe
Stretched
Debt / equity
0.01×
Interest coverage
0.0×
Current ratio
2.35×
BioRestorative Therapies, Inc.
BRTX
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
BioRestorative Therapies, Inc.
BRTX
NASDAQ
·
USD
·
Closed
$0.20
−9.22%
$0.20
−$0.02 (9.22%)
52W Range
3th
pctl
Volume
0.09×
avg
Mkt Cap
1.84M
USD
P/E
-0.2
TTM
Div Yield
–
ann
52W Range
3th
pctl
Volume
0.09×
avg
Market Cap
1.84M
USD
P/E Ratio
-0.2
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings